Abstract
Acute myeloid leukemia (AML) is a complex and heterogeneous hematologic neoplasm, characterized by uncontrolled proliferation of myeloid cells in the bone marrow. The standard treatment includes intensive induction chemotherapy with anthracycline and cytarabine (Ara-C), but high relapse rates underscore the need for new therapeutic strategies. Previous studies report that cholesterol play…